To the Editor,
We read with interest the study by S Kumar et al. that noted that patients with new Gastrointestinal (GI) bleeding during admission to ICU were more likely to die during hospitalisation. 1 GI bleeding cannot always be controlled or identified at gastroscopy (OGD), therefore guidelines recommend radiological intervention. 2 3 Radiological intervention may be of value in uncontrolled GI bleeding where a lesion has already been identified at endoscopy or if no lesion has been detected endoscopically but the patient continues to be haemodynamically unstable. Fluoroscopic angiography (FA) is time consuming, requires significant expertise, and has significant ionising radiation exposure. However, the recent advent of computed tomography angiography (CTA) potentially offers a sensitive, rapid and accurate diagnosis of the source of persisting GI bleeding and has a lesser risk of vessel dissection or damage than catheter angiography. For these reasons it is sometimes used as the new radiological first line test by comparison to FA. 2 3 Historically, surgery would be considered for refractory bleeding however there are currently no randomised controlled trials comparing surgery and radiological approaches.
There is limited data on CTA and for this reason we wanted to present the first UK study in the context of the international literature. Our non-systematic review of the literature using the search Mesh P M July 2017 and our study resulted in 6 studies in total that showed the application of CTA in upper GI bleeding. (Table 1 ) The use of * allowed for all suffixes to be accepted.
Our retrospective analysis of endoscopy and radiology databases was used to identify patients who underwent radiological intervention for GI bleeding at Sheffield Teaching Hospitals over a ten year period. Pre-endoscopy Rockall scores, routine haematology and biochemistry results taken prior to endoscopy and inpatient mortality rates were compared. respectively p<0.0001). There were no significant differences between CTA and FA patients.
No comborbidities were related to angiography. Six patients had surgical intervention for persisting bleeding. In a further seven it was suggested that if re-bleeding occurred, they would require surgical intervention but these individuals remained haemodynamically stable. Inpatient mortality rates were higher in those who underwent CTA prior to FA (22%) compared to those who went directly to FA (11%) but this was not significant (p=0.5). The re-bleeding rate of the whole cohort was 1.6%.
In conclusion, CTA has a diagnostic yield of 56.1% and embolization rate of 69.6% in this UK study. This data allows for appropriate counselling of patients being considered for CTA and should be considered in patients in the ICU setting with new GI bleeding. Our study demonstrates the role for CT angiogram in UGIB however larger studies are needed before incorporation to newer guidelines developed. 
